Productive healthy ageing: interventions for quality of life

Public Health England, March 2019

This document lists interventions that can be made by pharmacy teams, to help older people to lead more independent lives and improve their health.

The document includes interventions based around:

  • preventing falls
  • dementia
  • physical inactivity
  • social isolation, and loneliness
  • malnutrition

In addition to pharmacy teams, the guidance can be consulted by pharmaceutical and medical committees, local authorities, clinical commissioning groups and local NHS England teams.

Click here to view the document.

Polypharmacy: getting our medicines right

Royal Pharmaceutical Society, February 2019

This guidance is for pharmacists and all healthcare organisations involved with medicine and provides a summary of the scale and complexity of the issue of polypharmacy. The guidance outlines how healthcare professionals, patients and carers can find solutions when polypharmacy causes problems for patients and points to useful resources that can help.  The guidance recommends that all healthcare organisations have systems in place to ensure people taking 10 or more medicines can be identified and highlighted as requiring a comprehensive medication review with a pharmacist.

Click here to view the guidance.

In Good Health: A Report following the All Party Pharmacy Group’s 2018 Inquiry into Long Term Conditions

All Party Pharmacy Group, July 2018

Report from the All Party Pharmacy Group that recommends:

  1. Patients with one or more condition must have access to a care plan, giving them control over how their condition is managed, that they can review. Community pharmacy is ideally placed to manage this.
  2. Calls for  for pharmacists tohave full read/write access to patient records and service and contract integration with primary care.
  3. Community pharmacy should be a signposting service to services delivering a high standard of care, currently the offer is not universal.
  4. Innovative community pharmacy services should be commissioned at a national level once their effectiveness and value for money has been demonstrated at a local level.

Click here to view the full report.

Medicines optimisation in care homes: Programme overview

NHS England, March 2018

This document sets out the process for how the Pharmacy Integration Fund (PhIF) will be deployed to support the Medicines optimisation in care homes (MOCH) programme in 2018/19 and 2019/20. It sets out the background to the programme and describes the scope, objectives and expected outcomes for care home residents. This programme aims to recruit pharmacists into care homes to help reduce overmedication and cut unncessary hospital stays.

Click here to view the full report.

Prevalence and economic burden of medication errors in the NHS in England: Rapid evidence synthesis and economic analysis of the prevalence and burden of medication error in the UK

University of Sheffield Policy Research Unit in Economic Evaluation of Health & Care Interventions, March 2018

Report that estimates approximately 66 million potentially clinically significant errors occur per year, 71.0% of these in primary care. This is where most medicines in the NHS are prescribed and dispensed. Prescribing in primary care accounts for 33.9% of all potentially clinically significant errors. It estimates NHS costs of definitely avoidable Adverse Drug Reactions as £98.5 million per year, consuming 181,626 beddays, causing 712 deaths, and contributing to 1,708 deaths.

Click here to view the full report.

The Report of the Short Life Working Group on reducing medication-related harm

Department of Health and Social Care, March 2018

Report on the recommendations of the Short Life Working Group (SLWG) on reducing medication-related harm the focus is on the World Health Organizations domains:

  1. Patients and the Public
  2. Health Care Professionals
  3. Medicines
  4. Systems and Practice of medication

It also identifies the role of technology.

Click here to view the full report.

The pharmacy contribution to antimicrobial stewardship

Royal Pharmaceutical Society – September 2017

This report looks at the pharmacist’s role in tackling the challenges of inappropriate use of antibiotics as part of a multidisciplinary approach. The report makes recommendations in order to contribute to wider efforts in meeting the challenge set by the UK Government in 2016 of reducing inappropriate antibiotic prescribing by 50 per cent by 2020.

Click here to view the full report.